Exploitation of drug-induced Bcl-2 overexpression for restoring normal apoptosis function: A promising new approach to the treatment of multidrug resistant cancer☆
To access this article, please choose from the options below
☆ This work was support by The Parke-Davis Endowed Chair in Pharmaceutics and Drug Delivery and NIH AI51214.
PII: S0304-3835(07)00031-6
doi:10.1016/j.canlet.2007.01.018
© 2007 Elsevier Ireland Ltd. All rights reserved.
